An Imaging Company for Ophthalmic Clinical Trials
innovation variation2.jpg

Rare & Orphan Retinal Degeneration

Rare & Orphan Retinal Degeneration

There has been major interest in therapeutic options under investigation for the treatment of previously untreatable Rare or Orphan diseases in ophthalmology. Gene and stem cell therapies are several possible avenues being closely investigated potential therapeutic options. Some examples of these diseases are Retinitis Pigmentosa, Ushers Syndrome, Stargardt’s Disease and Lebers Congenital Amaurosis.

Retinitis Pigmentosa

Retinitis Pigmentosa (RP) is a group of rare, inherited disorders characterized by breakdown and loss of retinal cells caused by abnormalities in the photoreceptors. More than 50 genes have been associated with mutations leading to classical symptomology noted in RP. Symptoms of RP appear throughout the lifecycle and include reduced night vision, photosensitivity, loss of peripheral vision, progressing to reading difficulty, impaired mobility secondary to decreased clarity of vision, and discerning faces or objects. Ultimately, most people with RP will lose much of their sight.

Lebers Congenital Amaurosis

Leber’s Congenital Amaurosis is an inherited disorder that primarily affects the retina. It generally causes severe visual impairment beginning in infancy. Vision loss tends to be steady, although it may deteriorate gradually over time. Visual acuity is rarely better than 20/400.

Usher Syndrome

Usher Syndrome is a condition affecting both hearing and vision loss. The primary symptoms are hearing loss and Retinitis Pigmentosa (RP). People with Usher Syndrome may have difficulty with balance.

Stargardt’s Disease

Stargardt’s Disease is an inherited disorder of the retina. Vision loss usually occurs during childhood or adolescence, although in some forms may not be noticed until later in adulthood. Disease progression varies, but people with earlier symptom onset tend to experience more rapid vision loss. The most common symptom is progressive, bilateral central vision loss. The loss progresses slowly to a range of 20/200 to 20/400. Complete loss of central vision is rare.

Imaging modalities and endpoints

The typical imaging modalities used to document, categorize and monitor treatment of the and other orphan diseases include Fundus Photography, Fluorescein Angiography , Optical Coherence Tomography and Electrophysiology testing .

Lebers Disease

Ushers Syndrome

Stargardt’s Syndrome

Stargardt’s Syndrome on OCT

Images Courtesy of Tim Steffens